Diverse subsets of endothelial progenitor cells (EPCs) are used for the treatment of ischemic
diseases in clinical trials, and circulating EPCs levels are considered as biomarkers for …

Background Frailty is strongly associated with adverse cardiovascular outcomes; however,
the underlying pathophysiological processes are largely unknown. Vascular endothelial …

Endothelial progenitor cells (EPCs) are involved in the maintenance of endothelial
homoeostasis and in the process of new vessel formation. Experimental and clinical studies …

Neovascularization and angiogenesis are vital processes in the repair of damaged tissue,
creating new blood vessel networks and increasing oxygen and nutrient supply for …

Heterotopic ossification (HO) is a debilitating condition characterized by the pathologic
formation of ectopic bone. HO occurs commonly following orthopedic surgeries, burns, and …

Abstract Aims MicroRNA-126 (miR-126), which is enriched in endothelial cells, plays a role
in angiogenesis. Based on the seed sequence, miR-126 can also be predicted to regulate …

Background Neovascularization is impaired in diabetes mellitus, which leads to the
development of peripheral arterial disease and is mainly attributed to the dysfunction of …

Abstract The concept of Endothelial Progenitor Cells (EPCs) therapy for adult
neovascularization has continuously received attention. They are believed to participate in …

Hematopoiesis is a complex and intricate process that aims to replenish blood components
in a constant fashion. It is orchestrated mostly by hematopoietic progenitor cells …

Background—The aim of this study was to determine the role of the chemokine receptor
CXCR7 in atherosclerosis and vascular remodeling. CXCR7 is the alternative receptor of …